Freenome, Inc. (FRNM) Ownership
FRNM ownership summary
as of October 17, 2026- Institutions
- 40.1% of shares outstanding
- Insiders
- 25.95% of shares outstanding
- Shares outstanding
- 107.4M
- Float
- 49.8M shares available to trade
- Short interest
- — 3.4M shares short
- Days to cover
- 3.68 short interest up 100.4% vs prior month
- Institutions 40.07%
- Insiders 25.95%
- Other investors 33.98%
FRNM top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | T. Rowe Price Small-Cap Stock | 1.06% | 1.1M | $13.3M | — | August 31, 2026 |
| 2 | ARK Genomic Revolution ETF | 0.68% | 731K | $8.6M | +1,788 (+0.2%) | September 30, 2026 |
| 3 | T. Rowe Price Instl Small-Cap Stock | 0.57% | 615K | $7.2M | — | August 31, 2026 |
| 4 | abrdn Healthcare Opportunities | 0.42% | 448K | $5.3M | +52,289 (+13.2%) | August 31, 2026 |
| 5 | Fidelity Growth Company Fund | 0.37% | 397K | $4.7M | — | August 31, 2026 |
| 6 | abrdn World Healthcare | 0.27% | 291K | $3.4M | +34,460 (+13.4%) | August 31, 2026 |
| 7 | Schwab US Small-Cap ETF™ | 0.26% | 280K | $3.3M | +189 (+0.1%) | September 30, 2026 |
| 8 | iShares Core S&P Total US Stock Mkt ETF | 0.08% | 83K | $969,622 | +70 (+0.1%) | September 30, 2026 |
| 9 | Fidelity Growth Company K6 | 0.07% | 76K | $888,664 | — | August 31, 2026 |
| 10 | Fidelity Series Growth Company | 0.07% | 74K | $864,236 | −6,400 (−8.0%) | August 31, 2026 |
| 11 | Fidelity Nasdaq Composite Index | 0.07% | 73K | $859,524 | +67,562 (+1,208.8%) | August 31, 2026 |
| 12 | JHVIT Health Sciences I | 0.05% | 51K | $594,010 | +24,168 (+91.6%) | August 31, 2026 |
| 13 | ARK Genomic Revolution ETF A USD Acc | 0.04% | 41K | $479,988 | — | September 30, 2026 |
| 14 | 1290 VT Micro Cap K | 0.04% | 39K | $458,908 | +39,056 (0.0%) | August 31, 2026 |
| 15 | Fidelity Nasdaq Composite ETF | 0.04% | 38K | $449,919 | — | September 30, 2026 |
| 16 | EQ/T. Rowe Price Health Sciences IB | 0.03% | 35K | $415,609 | +20,536 (+138.4%) | August 31, 2026 |
| 17 | Schwab US Broad Market ETF™ | 0.03% | 33K | $384,672 | +48 (+0.1%) | September 30, 2026 |
| 18 | T. Rowe Price Spectrum Mod Gr Allc | 0.03% | 32K | $376,153 | — | August 31, 2026 |
| 19 | T. Rowe Price Spectrum Moderate Allc Inv | 0.01% | 13K | $154,583 | — | August 31, 2026 |
| 20 | T. Rowe Price Health Care ETF | 0.01% | 11K | $129,144 | — | September 30, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
Who owns FRNM
Institutional investors own 40.1% of Freenome's shares and insiders 25.95%.
Related: FRNM analyst forecast, FRNM key metrics. See the FRNM stock overview for the latest quote and news.
FRNM ownership FAQ
What percentage of Freenome is owned by institutions?
Institutions hold 40.1% of Freenome's shares outstanding; insiders hold 25.95%.
Which funds own Freenome?
The largest fund holders of Freenome are T. Rowe Price Small-Cap Stock (1.06%), ARK Genomic Revolution ETF (0.68%), T. Rowe Price Instl Small-Cap Stock (0.57%), abrdn Healthcare Opportunities (0.42%), Fidelity Growth Company Fund (0.37%).
How many shares of Freenome are outstanding?
Freenome has 107.4M shares outstanding, of which 49.8M are in the public float.